Comparison of radial versus femoral access in patients undergoing invasive management for acute coronary syndromes: evidence from a systematic review and.

Slides:



Advertisements
Similar presentations
Impact of Diabetes Mellitus on Early and Long-term Results of Percutaneous Drug- eluting Stent Implantation for Unprotected Left Main Coronary Disease.
Advertisements

Allen Jeremias MD MSc, Sanjay Kaul MD, Luis Gruberg MD, Todd K. Rosengart MD, David L. Brown MD Divisions of Cardiovascular Medicine and Cardiothoracic.
1 SUPERIORITY OF A HIGH CLOPIDOGREL LOADING DOSE REGIMEN IN PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION: EVIDENCE FROM A META-ANALYSIS G. BIONDI-ZOCCAI1,
Radial versus Femoral Randomized Investigation in ST Elevation Acute Coronary Syndrome the RIFLE STEACS study Enrico Romagnoli, MD PhD Principal investigators:
Giuseppe Biondi-Zoccai Division of Cardiology, University of Turin, Turin, Italy.
Published in Circulation 2005 Percutaneous Coronary Intervention Versus Conservative Therapy in Nonacute Coronary Artery Disease: A Meta-Analysis Demosthenes.
A meta-analysis of percutaneous versus surgical closure of ostium secundum atrial septal defects Butera G, Biondi-Zoccai G, Abella R, Piazza L, Chessa.
A Systematic Review On The Hazards Of Aspirin Discontinuation Among Patients With Or At Risk For Coronary Artery Disease Giuseppe Biondi Zoccai Hemodynamics.
Prasugrel vs. Clopidogrel for Acute Coronary Syndromes Patients Managed without Revascularization — the TRILOGY ACS trial On behalf of the TRILOGY ACS.
1 SIROLIMUS-ELUTING STENTS FOR IN-STENT RESTENOSIS TREATMENT IN 278 UNSELECTED PATIENTS: INSIGHTS ON LONG-TERM OUTCOMES FROM A LARGE TWO-CENTER REGISTRY.
Radial versus Femoral Approach for Percutaneous Coronary Procedures: A Meta-analysis of Randomized Trials 6th EUROPEAN WORKSHOP ON TRANSRADIAL APPROACH.
TRI vs TFI in STEMI Shenyang Northern Hospital Wang Shouli Han Yalin.
Title1 Brain Natriuretic Peptide Levels Have A Significant Prognostic Role In Patients With Suspected Or Confirmed Acute Pulmonary Embolism: Evidence From.
1 Percutaneous Below-The-Knee Stent Implantation Among 468 Patients With Critical Limb Ischemia: Pooled Analysis And Comparison Of Drug-Eluting Versus.
Effect of Switching Antithrombin Agents for Primary Angioplasty in Acute Myocardial Infarction The HORIZONS-SWITCH Analysis HORIZONS AMI Dangas G, et al.
Left Main Trifurcation Disease: Early and Long-Term Outcomes Of Percutaneous Coronary Intervention I.Sheiban, A.Gerasimou, F. Sciuto, P.Omedè, G. Biondi.
Intravascular ultrasound does not provide any significant clinical benefit for percutaneous coronary intervention of bifurcation lesions Giuseppe Biondi.
1 HIGH CLOPIDOGREL LOADING DOSE IS SUPERIOR TO A STANDARD 300 MG REGIMEN IN PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION: EVIDENCE FROM A META-ANALYSIS.
1 Efficacy of a novel anti-inflammatory drug-eluting balloon coated with genistein before stent implantation in porcine coronary arteries I. Sheiban, C.
1 Superiority Of A Simple Stenting Strategy For Coronary Bifurcation Lesions In The Drug-Eluting Stent Era: Evidence From A Meta-Analysis Of 1141 Patients.
Giuseppe Biondi Zoccai University of Turin, Turin, Italy METCARDIO, Turin, Italy BMS & Sanofi Aventis Sponsored.
Is there any role for intravascular ultrasound in bifurcation lesions? Giuseppe Biondi-Zoccai, MD University of Turin, Turin, Italy.
4 th European Bifurcation Club September PRAGUE A comprehensive meta- analysis on drug-eluting stenting for unprotected left main disease.
Date of download: 6/3/2016 From: Radial Versus Femoral Access in Invasively Managed Patients With Acute Coronary Syndrome: A Systematic Review and Meta-analysis.
Date of download: 7/8/2016 Copyright © The American College of Cardiology. All rights reserved. From: Comprehensive Meta-Analysis of Safety and Efficacy.
1 R1 임준욱 Anticoagulant and Antiplatelet Therapy Use in 426 Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention and Stent Implantation.
From: Bivalirudin Versus Heparin With or Without Glycoprotein IIb/IIIa Inhibitors in Patients With STEMI Undergoing Primary Percutaneous Coronary Intervention:
Pros and Cons of Radial Access
insights from a meta-analysis of
The European Society of Cardiology Presented by Dr. Bo Lagerqvist
Clinical need for determination of vulnerable plaques
Primer on Adjusted Indirect Comparison Meta-Analyses
Women, Bleeding, and Coronary Intervention
Radial vs Femoral Access in ACS Patients
Coronary Catheterization and Percutaneous Coronary Intervention in China 10-Year Results From the China PEACE-Retrospective CathPCI Study Xin Zheng,
Giuseppe Biondi Zoccai
Figure 3 Ischaemic outcomes in the ST-segment elevation myocardial
Diabetes mellitus in patients undergoing percutaneous drug-eluting stent implantation: short and long-term results Claudio Moretti, M.D. Division of Cardiology,
Background There is ongoing debate to identify the most effective drug-eluting stent between the two currently most used devices (ie, sirolimus- [SES]
Giuseppe Biondi Zoccai University of Turin, Turin, Italy
NOACS: Emerging data in ACS/IHD
Compare-Acute Trial design: STEMI patients undergoing primary PCI were randomized to fractional flow reserve (FFR)-guided complete revascularization (n.
Figure 2 Ischaemic and bleeding outcomes in the major clinical trials
Incidence And Management Of Restenosis After Treatment Of Unprotected Left Main Disease With Drug-Eluting Stents: 70 Restenotic Cases From A Cohort Of.
Giuseppe Biondi Zoccai, MD
AN INTERNATIONAL COLLABORATIVE META-ANALYSIS ON 1,274 PATIENTS UNDERGOING PERCUTANEOUS DRUG-ELUTING STENTING FOR UNPROTECTED LEFT MAIN CORONARY ARTERY.
P. Omedé,1 A. Abbate,4 G. P. Trevi,1 and I. Sheiban1
TRIAL HIGHLIGHT FROM ESC 2016: ACUTE CORONARY SYNDROMES
% Heparin + GPI IIb/IIIa Bivalirudin +
After Eighty Study Trial design: Elderly patients with non–ST-elevation acute coronary syndrome (NSTE-ACS) were randomized to invasive therapy (n = 229)
American College of Cardiology Presented by Dr. Michel R. Le May
Incidence and management of restenosis after treatment of unprotected left main disease with drug-eluting stents: 70 restenotic cases from a cohort of.
PREDICTORS OF ADVERSE EVENTS IN PATIENTS WITH UNPROTECTED LEFT MAIN DISEASE TREATED WITH DRUG-ELUTING STENTS: EVIDENCE FROM A COLLABORATIVE META-REGRESSION.
Global Registry of Acute Coronary Events: GRACE
BENEFITS OF CLOPIDOGREL IN PATIENTS UNDERGOING CORONARY STENTING SIGNIFICANTLY DEPEND ON LOADING DOSE: EVIDENCE FROM A SYSTEMATIC REVIEW AND META-REGRESSION.
Single Versus Multiple Vessel Stenting In Patients With St-Elevation Myocardial Infarction: Results From A 30,886-Patient Meta-Analysis Giuseppe Biondi.
ARISE Trial Aggressive Reduction of Inflammation Stops Events
ORAL CILOSTAZOL TREATMENT PREVENTS RESTENOSIS AND MAJOR ADVERSE CLINICAL EVENTS AFTER DRUG-ELUTING STENT IMPLANTATION: EVIDENCE FROM A META-ANALYSIS G.
Maintenance of Long-Term Clinical Benefit with
OASIS-5: Study Design Randomize N=20,078 Enoxaparin (N=10,021)
DEScover: One-Year Clinical Results
Is Prasugrel Superior To Ticagrelor For The Treatment Of Patients With Acute Coronary Syndromes? Evidence From A 32,893-Patient Adjusted Indirect Comparison.
SOLID-TIMI 52 Trial design: Participants within 30 days of an acute coronary syndrome (ACS) were randomized to darapladib 160 mg daily (n = 6,504) versus.
Sirolimus Stent vs. Bare Stent in Acute Myocardial Infarction Trial
IVUS-XPL Trial design: Patients undergoing drug-eluting stent implantation for long coronary lesions were randomized to IVUS-guided PCI (n = 700) vs. angiography-guided.
ST-segment elevation myocardial infarction in China from 2001 to 2011 (the China PEACE-Retrospective Acute Myocardial Infarction Study): a retrospective.
MATRIX: Radial vs. Femoral
MRRs and EMRRs for women with ACS
Ticagrelor versus prasugrel; risk ratio with 95% CIs for the primary composite end point, primary composite end point in those undergoing PCI, myocardial.
Adjusted. ORs for outcomes by maintenance P2Y12 treatment
Presentation transcript:

Comparison of radial versus femoral access in patients undergoing invasive management for acute coronary syndromes: evidence from a systematic review and meta-analysis G. Biondi-Zoccai,1 C. Moretti,1 F. Sciuto,1 P. Omedé,1 E. Cavallero,1 C. La Spina,1 V. Infantino,1 F. Colombo,1 E. Giraudi,1 E. Menditto,1 C. Iacovino,1 P. Agostoni,2 E. Romagnoli,3 M. Bollati,1 G. Trevi,1 I. Sheiban1 1University of Turin, Turin, Italy (gbiondizoccai@gmail.com); 2AZ Middelheim, Antwerp, Belgium; 3Policlinico Casilino, Rome, Italy

BACKGROUND An invasive management encompassing coronary angiography and, when indicated, percutaneous coronary intervention (PCI), is recommended in most high-risk patients with acute coronary sindromes (ACS). However, adverse events, especially local access site bleeding, are not uncommon. The radial approach has been proposed as an alternative to the femoral access to minimize bleedings in ACS, but data are so far unclear.

AIM OF OUR WORK We thus performed a comprehensive meta-analysis of randomized trials comparing radial vs femoral access in patients with ACS undergoing coronary angiography ± PCI.

METHODS We performed a meta-analysis of all studies published up to April 2008 comparing radial versus femoral access in patients with ACS, by means of systematic database search (clinicaltrials.gov, Google Scholar, PubMed), and data appraisal. The primary end-point was the occurrence of net adverse clinical events (NACE), defined as the composite of death, myocardial infarction (MI), repeat revascularization (ie major adverse cardiac events [MACE]) plus major bleeding. Odds ratios (OR) and weighted mean differences (WMD) were computed by means of fixed-effect methods.

Pts with femoral access INCLUDED STUDIES Study Year Pts with radial access Pts with femoral access STEMI (%) FARMI 2007 57 100% Mann et al 1998 68 77 14% RADIAL-AMI 2005 25 TEMPURA 2003 72

RESULTS A total of 4 randomized controlled trials were included, enrolling a total of 458 patients (227 randomized to radial access and 231 randomized to femoral access). Most (326) patients presented with acute ST-elevation myocardial infarction. At hospital discharge, the radial access was associated with significant reductions in the rate of net adverse clinical events in comparison to the femoral access (24/227 [10.5%] vs 36/231 [15.6%], p=0.05).

RESULTS Similarly beneficial yet statistically non-significant trends were also seen for death (7/227 [3.1%] vs 11/231 [4.8%]), major adverse cardiac events (21/227 [9.3%] vs 27/231 [11.7%]), and major bleedings (3/227 [1.3%] vs 9/231 [3.9%]; all p>0.05). Radial access was also associated with a significant reduction in length of hospital stay (weighted mean difference 1.0+-0.1 days, p<0.001).

RISK OF DEATH RISK OF MAJOR BLEEDING

RISK OF MACE RISK OF NACE

RISK OF ACCESS SITE COMPLICATIONS RISK OF PROCEDURAL FAILURE

TOTAL LENGTH OF HOSPITAL STAY IN DAYS Review: Radial vs femoral access in patients undergoing invasive management for acute coronary syndromes (1 August 2008) Comparison: 01 Comparison of radial versus femoral access for acute coronary syndromes Outcome: 07 Length of hospital stay Study Radial Femoral WMD (fixed) WMD (fixed) or sub-category N Mean (SD) N Mean (SD) 95% CI 95% CI Mann 1998 68 3.00(0.30) 77 4.50(0.50) -1.50 [-1.63, -1.37] TEMPURA 2003 77 5.70(4.90) 72 7.40(9.50) -1.70 [-4.15, 0.75] RADIAL-AMI 2005 25 4.00(1.00) 25 4.00(1.00) 0.00 [-0.55, 0.55] FARMI 2007 57 7.20(0.50) 57 7.50(0.40) -0.30 [-0.47, -0.13] Total (95% CI) 227 231 -1.00 [-1.10, -0.90] Test for heterogeneity: Chi² = 135.64, df = 3 (P < 0.00001), I² = 97.8% Test for overall effect: Z = 19.26 (P < 0.00001) -10 -5 5 10 Favors radial Favors femoral

CONCLUSIONS The radial access should be considered as the first choice vascular approach in most patients with unstable coronary artery disease managed invasively, given the evident overall clinical benefits. This holds even truer for those at higher risk of adverse events, such as the elderly, women and those undergoing rescue intervention for failed thrombolysis.

For further slides on these topics please feel free to visit the metcardio.org website: http://www.metcardio.org/slides.html